… As has typically been the case drug repurposing programmes, the interest in metformin was
… were less likely to develop cancer compared to patients on other diabetes drugs [5]. This …

… Also the heterogeneity of AML will likely demand a broader repertoire of therapeutic molecules.
Drug repurposing or repositioning represent a source for potential therapeutics with well-…

… the drug repurposing with a major focus on breast cancer. BC is a division of cancer known
as … The sluggish progression in developing new therapeutic drugs is partly due to the safety …

… or inhibition of proliferation in proper cell culture environment of different cancer cells [46–48].
Also, genetic expression study of drugs based on cell line can help in drug repurposing. …

… While majority of cancer cells within a … therapeutic agents prompting cancer recurrence
with time. This renders the need for novel targeted therapeutic approaches for “repurposed drugs…

… indicate new therapeutic targets, thereby identifying novel therapeutic actions for already
approved medicines, which is called drug repurposing. The strategy of drug repurposing, also …

… for established drugs. By examining the multifaceted landscape of drug repurposing, this
review aims to offer comprehensive insights into its potential to transform cancer therapeutics. …

… types to the exploration of non-cancer drugs as new cancer therapeutics (Pushpakom … -cancer
drugs as potential cancer therapeutics. To this end the list of drugs classed as repurposing …

… However, despite the promising initial results, available cancer therapeutics have limitations
that hinder its clinical use or reduce its effectiveness. Although all currently available …

… several therapeutics, but the entire process is tedious. Drug repurposing, also called drug
… opportunities to use approved or investigational drugs that are outside the scope of the …